IEC 60601 Electrical Safety and EMC Testing for Iran Registration

Updated: 2026-11-11 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

Active devices submitted in Iran require IEC 60601 series electrical safety and electromagnetic compatibility test reports, but Iranian review looks beyond the clauses of the standards themselves to the adaptation of the device to the local grid and environment. The judgement of GRZAN is that this is a hidden test point — one that is “not written on any checklist but always asked during review”. Its typical form is follow-up questioning about voltage fluctuation on the 220V grid and high-temperature summer operating conditions; companies that arrive unprepared will receive deficiency requests at exactly this point. The question is predictable, and a predictable question can be answered in advance inside the dossier itself.

  • Active devices need IEC 60601 series electrical safety and EMC test reports for submission in Iran.
  • Review extends beyond the standard clauses to whether the device adapts to the local power grid and environment. That question appears in review even though it appears on no checklist.
  • The hidden test point is the 220V grid with its fluctuations, combined with high summer temperatures.
  • Companies that have not prepared grid and temperature answers in advance will be issued deficiency requests here. Preparing grid and temperature answers in advance is entirely within the applicant’s control, and the dossier is the place to show that preparation.

2. Legal basis

The legal and normative references supporting this module are the following.

  1. The IEC 60601-1 series (basic safety and essential performance of medical electrical equipment) and 60601-1-2 (electromagnetic compatibility): international standards generally accepted by the Iranian authorities; where a corresponding ISIRI standard exists, conformity is judged against the ISIRI standard — this is a practical estimate.
  2. Adaptation to the local grid and environment: the civil and medical power supply in Iran is 220V; some regions experience high summer temperatures — this is a practical estimate, and the specific parameters must be verified against the installation site of the equipment.
  3. Law on the Administration of Medical, Pharmaceutical and Food-Beverage Affairs, FAOLEX LEX-FAOC227692, 1955-06-20, Article 3.

3. Expert insights

Insight 1: compliance with a standard does not equal usability on site. The test conditions of IEC 60601-1 are normally based on a standard laboratory environment, which is precisely why the reports are comparable between laboratories and between devices. But the actual operating conditions in Iran are not a standard laboratory: the device will run on a 220V grid that fluctuates, and in summer it may run in high ambient temperatures. What the reviewer wants to know is not whether the device passed the laboratory tests — that much the report already shows — but whether it will run stably under the conditions it will actually face. This question never appears as a line item in any published checklist, yet it recurs in review with remarkable consistency, and an answer already standing in the dossier reads as diligence rather than damage control. The applicant who has already prepared the answer in the dossier removes the question before it is asked.

Insight 2: mutual recognition of reports depends on laboratory accreditation. Whether a report issued by an international laboratory is accepted depends on whether that laboratory operates within the ILAC/IAF mutual recognition framework. A technically excellent report from a laboratory outside the framework can turn out to be unusable for the submission — a failure that is discovered only after the testing has been paid for and completed. GRZAN therefore recommends confirming the laboratory’s accreditation status before samples are sent for testing. The check takes a short conversation; the alternative is repeating an entire test campaign under a different laboratory, which is one of the most avoidable ways to lose time in an Iranian project. Accreditation is verifiable in advance, which makes it one of the few review risks that can be eliminated before any money is spent on testing.

Insight 3: electromagnetic compatibility attracts closer attention in dense medical environments. Large Iranian hospitals operate a high density of equipment in confined spaces, so the real-world electromagnetic behaviour of a device — and of the devices around it — receives genuine attention in review. A standard EMC report demonstrates conformity in a controlled setting; it does not describe how the device behaves when installed among dozens of other active devices. Providing a statement of the intended installation conditions helps close this gap: it shows the reviewer that the applicant has thought about spacing, earthing and the electromagnetic environment the device will share, rather than treating EMC as a certificate to be filed and forgotten. The statement costs a page; the doubt it prevents can cost a review cycle.

4. Practical recommendations

  • Submit a grid adaptation statement: state clearly the device’s ability to operate at 220V and across the fluctuation range, with test data attached. The data turn the claim into evidence.
  • Add high-temperature operating verification: issue a stability verification based on the highest ambient temperature of the installation site. Document it with the same discipline as the electrical safety testing.
  • Confirm laboratory accreditation: before samples are sent for testing, confirm that the laboratory operates within the ILAC/IAF mutual recognition framework, and record the confirmation in the project file.
  • Provide installation and electromagnetic environment notes: describe the installation spacing, earthing requirements and recommended electromagnetic environment management measures. These notes cost little and answer questions reviewers otherwise raise.

5. Verification checklist

  • □ IEC 60601-1 and 60601-1-2 test reports have been submitted and are within their validity period
  • □ A 220V grid adaptation statement with test data has been submitted
  • □ Stability verification has been completed at the highest ambient temperature of the installation site
  • □ The testing laboratory has been confirmed to operate within the ILAC/IAF mutual recognition framework
  • □ Notes on installation spacing, earthing and electromagnetic environment management have been provided

Regulatory information verified as of October 29, 2026

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Iranian market. Our team prepares IFDA-compliant dossiers, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail